You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis

Article metrics

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Review
Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis

 

Online download statistics by month:

Online download statistics by month: January 2020 to March 2026

AbstractFullPdf
Jan 202012120
Feb 202094940
Mar 202096964
Apr 2020676713
May 202038388
Jun 2020444430
Jul 2020505025
Aug 2020464619
Sep 2020575784
Oct 2020555543
Nov 2020666842
Dec 2020838345
Jan 2021767639
Feb 2021565633
Mar 2021505038
Apr 2021565638
May 20214949148
Jun 2021545476
Jul 2021646448
Aug 2021636326
Sep 2021464628
Oct 2021959369
Nov 2021717145
Dec 202112212245
Jan 202210110739
Feb 2022565727
Mar 202214814748
Apr 2022848622
May 2022889541
Jun 2022586027
Jul 2022616522
Aug 2022737523
Sep 2022808029
Oct 202210310552
Nov 2022767938
Dec 2022525317
Jan 2023868625
Feb 2023778232
Mar 2023889022
Apr 2023687026
May 2023646438
Jun 2023535320
Jul 2023707128
Aug 202346468
Sep 2023818125
Oct 2023909034
Nov 202311411725
Dec 202313814539
Jan 2024505057
Feb 2024909125
Mar 202412612883
Apr 202410910929
May 2024696922
Jun 2024696927
Jul 2024829325
Aug 2024656629
Sep 2024747632
Oct 2024505126
Nov 2024828328
Dec 202410610718
Jan 202510510723
Feb 202520120332
Mar 202518318326
Apr 202517617624
May 2025838435
Jun 2025585815
Oct 2025400
Jan 2026100
Feb 2026100
Total524953172209